SATHISH DYAWANAPELLY | Pharmacology and Drug Development | Young Scientist Award

Published on by Life Science

Young Scientist Award

SATHISH DYAWANAPELLY
Affiliation Institute of Chemical Technology (ICT), Mumbai
Country India
Scopus ID 56293760300
Documents 39
Citations 1947
h-index 24
Subject Area Pharmacology and Drug Development
Event World Life Science Awards

SATHISH DYAWANAPELLY is a researcher associated with the Institute of Chemical Technology (ICT), Mumbai, whose scholarly work has focused on pharmacology, nanomedicine, drug delivery systems, biomaterials, and pharmaceutical innovation. His research portfolio demonstrates sustained contributions to the advancement of drug development methodologies, polymer therapeutics, pulmonary delivery systems, nanovaccines, and translational pharmaceutical sciences. The combination of publication output, citation performance, and interdisciplinary research engagement provides a basis for consideration within academic recognition programs such as the Young Scientist Award.[1]

Abstract

This article presents an academic overview of SATHISH DYAWANAPELLY and evaluates his suitability for recognition through the Young Scientist Award. The assessment is based on publicly available scholarly indicators including publication productivity, citation performance, research specialization, and documented contributions to pharmaceutical sciences and drug delivery technologies. His work spans nanomedicine, cancer therapeutics, pulmonary formulations, biomimetic nanovaccines, and advanced pharmaceutical engineering, demonstrating interdisciplinary engagement within life science research.[1][2]

Keywords

Nanomedicine, Drug Delivery Systems, Pharmacology, Polymer Therapeutics, Pulmonary Drug Delivery, Pharmaceutical Sciences, Cancer Therapy, Biomaterials, Nanovaccines, Life Sciences.

Introduction

The development of modern therapeutics increasingly relies on innovative drug delivery technologies capable of improving efficacy, safety, and patient outcomes. Researchers working at the intersection of pharmaceutical sciences and nanotechnology contribute substantially to this objective. SATHISH DYAWANAPELLY has developed a research profile centered on advanced delivery systems, polymer-based therapeutics, and translational pharmaceutical technologies, contributing to emerging areas of life science research.[2][3]

Research Profile

Based at the Institute of Chemical Technology (ICT), Mumbai, SATHISH DYAWANAPELLY has established a scholarly record characterized by publications in internationally recognized journals and interdisciplinary collaborations. His Scopus metrics indicate 39 indexed documents, 1,947 citations, and an h-index of 24, reflecting measurable research visibility and influence within pharmacology and drug development.[1]

  • Specialization in pharmacology and advanced drug delivery systems.
  • Research involvement in nanomedicine and biomaterial-based therapeutics.

Research Contributions

The research contributions of SATHISH DYAWANAPELLY encompass several areas of pharmaceutical innovation. His studies have explored polymer therapeutics, pulmonary drug delivery systems, nanoparticle engineering, biomimetic nanovaccines, and cancer-targeted delivery technologies. These investigations address practical challenges associated with therapeutic effectiveness, bioavailability, and targeted treatment strategies.[2]

  • Polymer therapeutics and pharmacokinetic optimization.
  • Nanovaccine development and biomimetic delivery technologies.
  • Pulmonary drug delivery approaches for chronic diseases.

Publications

Selected publications associated with SATHISH DYAWANAPELLY demonstrate engagement with contemporary pharmaceutical research topics and high-impact translational applications.[2]

  1. The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Biodistribution.
  2. Understanding the Nano-Bio Interactions Using Real-Time Surface Plasmon Resonance Tool.
  3. Multifaceted Therapeutic Applications of Biomimetic Nanovaccines.

Research Impact

Citation metrics, publication quality, and subject relevance collectively indicate that the research activities of SATHISH DYAWANAPELLY have generated measurable scholarly attention. The citation count of 1,947 and h-index of 24 suggest that multiple publications have influenced subsequent investigations within pharmaceutical sciences and drug delivery research. Such indicators are commonly considered when evaluating research significance and scientific visibility.[1]

Award Suitability

The Young Scientist Award recognizes emerging and accomplished researchers who demonstrate innovation, scientific productivity, and meaningful contributions within their disciplines. Based on available scholarly indicators, SATHISH DYAWANAPELLY exhibits characteristics aligned with such recognition, including interdisciplinary research output, citation impact, active publication record, and contributions to pharmaceutical innovation. His work on advanced therapeutic delivery technologies aligns with contemporary priorities in life science and healthcare research.[1][2]

Conclusion

SATHISH DYAWANAPELLY has developed a notable academic profile within pharmacology and drug development through contributions to nanomedicine, drug delivery systems, biomaterials, and therapeutic innovation. The combination of publication productivity, citation performance, and interdisciplinary research engagement supports consideration for academic recognition programs such as the Young Scientist Award under the World Life Science Awards framework.[1]

References

  1. Sampathi, S., Tiriya, P. K., Dodoala, S., Junnuthula, V., & Dyawanapelly, S. (2022). Development of biocompatible ciprofloxacin–gold nanoparticle coated sutures for surgical site infections. Pharmaceutics, 14(10), Article 2130.
    https://doi.org/10.3390/pharmaceutics14102130
  2. Parihar, A., Prajapati, B. G., Paliwal, H., Shukla, M., Khunt, D., Bahadure, S. D., Dyawanapelly, S., & Junnuthula, V. (2023). Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis. Drug Discovery Today, 28(10), Article 103729
    https://doi.org/10.1016/j.drudis.2023.103729
  3. Iyer, G., Dyawanapelly, S., Jain, R., & Dandekar, P. (2022). An overview of oral insulin delivery strategies (OIDS).
    https://doi.org/10.1016/j.ijbiomac.2022.03.144

Iwona Polak | Molecular Biology | Best Researcher Award

Published on by Life Science

Ms. Iwona Polak | Molecular Biology | Best Researcher Award

University of Warmia and Mazury in Olsztyn | Poland

Iwona Polak, M.Sc. Eng., is a researcher at the University of Warmia and Mazury in Olsztyn, Faculty of Biology and Biotechnology, specializing in the molecular biology of parasitic nematodes from the Anisakidae family. Her scientific contributions focus on unraveling the molecular and proteomic mechanisms of Anisakis simplex, a parasite of marine mammals that poses risks to human health. With 11 published journal papers indexed in Scopus and other scientific databases, she has developed a strong academic record supported by 75 citations on ResearchGate and 57 citations on Scopus, reflecting her growing influence in parasitology and molecular biology. Her h-index of 4 demonstrates the consistent impact of her research output within her field. Through advanced transcriptomic and proteomic analyses, particularly using NGS and LC-MS/MS approaches, Polak’s work provides key insights into host–parasite interactions and parasite adaptation mechanisms. She has collaborated internationally with the Marine Research Institute (IIM-CSIC) in Vigo, Spain, in proteomics research. With one ongoing research project and plans to defend her doctoral thesis in biological sciences, she continues to expand her scientific profile and contribute to developing innovative therapeutic and control strategies for anisakiasis.

Featured Publications

Polak, I., et al. (2025). Diversity, expression, and structural modeling of sugar transporters in Anisakis simplex s. s. L3 and L4 larvae: An in vitro and in silico study. BMC Genomics, 26, Article 12068.

Polak, I., et al. (2025). Coupled transcriptome and proteome analysis of L3 and L4 developmental stages of Anisakis simplex s. s.: Insights into target genes under glucose influence. BMC Genomics, 26, Article 12069.

Polak, I., et al. (2024). The response of Anisakis simplex (s. s.) to anthelmintics: Specific changes in xenobiotic metabolic processes. International Journal for Parasitology: Drugs and Drug Resistance, 19, 80–92.